LifeTec Group

Name

LifeTec Group

Legal name

LifeTec Group BV

Website

https://lifetecgroup.com

Company type

Private

Founded year

2004

Operating status

Acquired

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Preclinical Contract Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Services-Commercial Physical & Biological Research (8731), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Nonclinical Study Management & Regulatory Writing (IND-enabling) (HLAGAFAN)

Keywords

• Preclinical contract research
• Medical device testing
• Biosimulation platforms
• Ex vivo organ perfusion
• Medtech R&D services

Headquarters

HQ city

Eindhoven

HQ country

Netherlands

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Preclinical Contract Research Services: Occasional studies using BioSimulation platforms and experienced engineering team for assessment studies. Acts as extension of client's own team.
2. BioSimulation Technology Sales and Lease: BioSimulation platforms available for intensive or long-term use as purchase or lease services. Includes platforms like Cardiac BioSimulator, PhysioHeart, BioLiver, OsteoChondral, and VABIO.
3. BioSkills Training and Workshops: Clinical training and workshop activities to introduce new device technology to clinical end-users using BioSimulation services.
4. Development and Manufacturing: Device prototyping services and full device development partnership through Resolution Medical connection. Manufacturing capabilities available for medical devices.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

LifeTec Group is a preclinical contract research organization that develops and operates proprietary BioSimulation platforms using real animal tissues (slaughterhouse hearts, livers, arteries, bone/cartilage) to test and train on cardiovascular, hepatic, vascular and osteochondral medical devices under physiologically realistic conditions. It sells or leases these platforms and provides preclinical research services, clinical BioSkills training, and prototyping/manufacturing support via its parent Resolution Medical.

Product overview

LifeTec Group is a preclinical contract research organization offering a portfolio of BioSimulator platforms and related services. The core products include six BioSimulator platforms: BioLiver (ex-vivo liver perfusion), Cardiac BioSimulator (beating heart simulator), PhysioHeart™ (isolated beating heart), OsteoChondral Platform (bone/cartilage cultivation), VAscular BIOreactor (VABIO), and Heart Valve Assessment Platform. These are supported by four service offerings: Preclinical Research Services (contract research using the platforms), BioSimulation Technologies (purchase/lease access), BioSkills Training & Workshops (clinical training), and Development & Manufacturing (prototyping through Resolution Medical). The company was acquired by Resolution Medical in 2022.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Slaughterhouse hearts can be used as cost-effective alternative to laboratory hearts for ex-situ heart perfusion studies with 100% functional survival
• +2 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• Atlantic Technological University (ATU)coreStrategic or Co-development Partner · 8 September 2025Atlantic Technological University announced collaboration with Resolution Medical and LifeTec Group to bring advanced BioSimulation technologies and device development expertise to Galway. The partnership supports startups and SMEs looking to accelerate medical device innovations. Cardiac BioSimulator demonstrations were performed in ATU's Medical Imaging Suite at the iHub.
• CoreMedicminorStrategic or Co-development Partner · 6 March 2025CoreMedic and LifeTec Group teamed up in a Eurostars-funded project aimed at advancing medical training and device development. This collaborative project focuses on enhancing medical training methodologies using biosimulation technologies.
• Resolution MedicalcoreStrategic or Co-development Partner · 1 June 2022Resolution Medical, a medical device CDMO and portfolio company of Arcline Investment Management, acquired LifeTec Group in June 2022. This acquisition integrated LifeTec's biosimulation services with Resolution Medical's device development and manufacturing capabilities. LifeTec brings early device prototyping services to Resolution Medical's European facility, while Resolution Medical provides 35,000 sq. ft. R&D facility in Minneapolis with state-of-the-art biosimulation lab.
• SINERGIA ConsortiumcoreStrategic or Co-development PartnerLifeTec Group participates in SINERGIA, a European research consortium focused on advanced technologies for drug discovery and precision medicine. The consortium includes 14 academic and industrial beneficiaries working on developing advanced in vitro models including ex vivo platforms. LifeTec contributes the BioLiver platform for research on liver interventions and tissue response.
• BIOGEL ConsortiumcoreStrategic or Co-development PartnerLifeTec Group participates in BIOGEL, a Marie Skłodowska-Curie ITN focused on developing innovative hydrogels for biomedical applications. LifeTec contributes by creating physiologically relevant 3D in vitro and ex vivo platforms to study biomaterial behavior and tissue interaction.
• Perinatal Life Support ConsortiumcoreStrategic or Co-development PartnerLifeTec Group participates in the EU-funded Perinatal Life Support project, a consortium including Eindhoven University of Technology, RWTH Aachen University, Politecnico Milano, and Nemo Healthcare. The project aims to create an artificial womb environment for premature infants. LifeTec contributes ex vivo technologies for testing oxygen and nutrient supply, cannulation, and blood circulation concepts.
• Catharina HospitalminorStrategic or Co-development PartnerCollaboration with Catharina Hospital Eindhoven on research using PhysioHeart platform for studying intracoronary cooling effects on myocardial reperfusion injury.
• Eindhoven University of TechnologycoreStrategic or Co-development PartnerLifeTec Group originated as spin-off from TU/e Department of Biomedical Engineering in 2004. Ongoing collaboration on research projects and technology development including cardiovascular biomechanics research.
• RegMed XBcoreStrategic or Co-development PartnerLifeTec Group collaborates with RegMed XB (Regenerative Medicine Cross-Border) on cardiovascular moonshot project developing regenerative technologies for repairing failing human hearts using PhysioHeart platform.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Charles River Laboratories: Large global CRO offering preclinical research, safety assessment, and biomedical device testing services. Comparable as a broad preclinical services provider where medical device manufacturers can outsource testing, but lacks LifeTec's specialized BioSimulation niche.
• TNO (Netherlands Organisation for Applied Scientific Research): Dutch applied research organization with biomedical and medical device preclinical capabilities including organ-on-chip and bio-imaging work. Comparable as a Dutch-based applied research organization offering preclinical testing for medical devices, though operating as a public research institute.
• WuXi AppTec: Major global preclinical CRO and CDMO offering a broad range of testing and development services. Comparable as a large preclinical research services provider, but operates at a different scale and breadth than LifeTec's specialized ex vivo organ platforms.

Direct peers

• TissUse GmbH: German multi-organ-chip company developing HUMIMIC chip platforms for preclinical substance and device testing. Closely comparable as a multi-organ preclinical platform provider targeting regulatory and industrial research customers.
• CN Bio Innovations: UK-based organ-on-chip and microphysiological systems company providing preclinical in vitro models for drug development and toxicology. Directly comparable to LifeTec as an alternative preclinical platform provider using advanced biological model systems for regulated research applications.
• Emulate Inc: US organ-on-chip technology company whose Organ-Chip platforms replicate human physiology for preclinical testing of drugs, chemicals, and devices. Competes with LifeTec's ex vivo organ approach as a more standardized, higher-throughput preclinical alternative.
• Mimetas B.V. Dutch organ-on-chip company offering OrganoPlate platforms for disease modeling, toxicology, and preclinical testing. Comparable as a Netherlands-rooted in vitro model platform company targeting pharma and medical device R&D customers.

Others

• Resonetics: US-based medical device contract manufacturer specializing in interventional and neuromodulation markets that has acquired Resolution Medical (LifeTec's parent). Connected as the ultimate corporate parent rather than a direct competitor, but provides context on the integrated manufacturing pipeline LifeTec now sits within.

Emerging players

• InSilicoTrials Technologies: Italy-based computational modeling platform providing in silico clinical trials for medical devices and drugs. Comparable as an alternative preclinical evidence-generation approach competing for the same MedTech R&D budget.
• Hesperos Inc: US company developing multi-organ human-on-a-chip systems for preclinical drug and disease modeling. Comparable as a specialized organ-model platform provider, though focused primarily on drug development rather than medical device testing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/lifetecgroup
• LinkedInlinkedin.com/company/lifetec-group

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LifeTec Group